Anti-CEACAM5/CEA/CD66e Antibody (Tusamitamab)
Catalog No.
F1504
Anti-CEACAM5/CEA/CD66e Antibody (Tusamitamab)
Featured Products
Tusamitamab is an IgG1 monoclonal antibody targeting CEACAM5. Tusamitamab is used to synthesize Tusamitamab ravtansine (SAR408701), a first-in-class humanized antibody-active molecule conjugate (ADC) combining Tusamitamab and DM4, a potent maytansine derivative.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
144.76 kDa
Dry ice
2349294-95-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
SAR-408377
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P06731
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CEACAM5 His at 2 ug/mL can bind Anti-CEACAM5/CEA/CD66e Antibody (Tusamitamab)
CEACAM5 / CEA / CD66e
Please avoid freeze-thaw cycles.